Clinical Trials Browser

NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07524894 2026-04-15

SNIFF

Phase 2 Not yet recruiting

126 enrolled

Head & Neck

Head and Neck Neoplasms

NCT07492914 2026-03-25

Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma

Phase 2 Not yet recruiting

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT07484139 2026-03-20

NEO COMBAT XL

Phase 2 Not yet recruiting

26 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07179315 2026-03-04

A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

Phase 2 Not yet recruiting

68 enrolled

Head & Neck

Head and Neck Neoplasms

NCT07418034 2026-02-18

SAVED

Phase 2 Not yet recruiting

132 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07214987 2026-01-30

PDT For Induction Therapy For Head And Neck Cancer

Phase 2 Not yet recruiting

26 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT07290946 2025-12-18

MESRIX-more

Phase 2 Not yet recruiting

100 enrolled

Head & Neck

Head and Neck Neoplasms, Sjogren's Syndrome, Xerostomia

NCT07254962 2025-11-28

CAPTURE

Phase 2 Not yet recruiting

75 enrolled

Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT07058805 2025-10-02

COMPORT

Phase 2 Not yet recruiting

50 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06998342 2025-05-31

MOHSAHRTSS

Phase 2 Not yet recruiting

24 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06894459 2025-04-30

A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Phase 2 Not yet recruiting

180 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06793761 2025-01-27

A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC

Phase 2 Not yet recruiting

260 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06660017 2024-10-26

Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse

Phase 2 Not yet recruiting

62 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06578871 2024-09-03

SUPERIOR

Phase 2 Not yet recruiting

90 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT06530524 2024-07-31

Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

Phase 2 Not yet recruiting

50 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06366945 2024-04-16

Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC

Phase 2 Not yet recruiting

85 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06360978 2024-04-11

Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer

Phase 2 Not yet recruiting

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT03865277 2023-09-11

INDIRA-MISO

Phase 2 Not yet recruiting

276 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms